Alzheimer's Disease Beyond Abeta
Organizer(s): JoAnne McLaurin and Tony Wyss-CorayDate: January 10 - 15, 2010
Location: Copper Mountain Resort, Copper Mountain, CO, USA
By 2010 many of the clinical trials presently underway targeting Abeta will have been completed or far enough along the pathway that we will have a better understanding of the benefit and limitations of this approach. This leads us to consider what are the next targets that will need to be addressed to fully treat and prevent Alzheimer’s disease. The objective of this meeting is therefore to stimulate and promote a discussion beyond Abeta as a key factor and therapeutic target in Alzheimer's Disease. This objective will be equally important whether therapeutic approaches targeting Abeta are successful or not, to either complement and expand successful Abeta therapies or to initiate a paradigm shift. In particular, we would like to discuss the generation of alternative models to study Alzheimer's Disease, and highlight several exciting areas of research including the role of synaptic dysfunction, neuronal regeneration, the immune system, and protein degradation in Alzheimer's Disease.
Scholarship Deadline: September 15 2009
Discounted Abstract Deadline: September 15 2009
Abstract Deadline: October 13 2009
Discounted Registration Deadline: November 10 2009
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:
Avid Radiopharmaceuticals, Inc.
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising: